Activating peripheral arterial disease patients to reduce cholesterol: A randomized trial

American Journal of Medicine

Volumn 124, Issue 6, 2011, Pages 557-565

  McDermott, Mary M ^a   Reed, George ^b   Greenland, Philip ^a   Mazor, Kathy M ^b   Pagoto, Sherry ^b   Ockene, Judith K ^b   Graff, Rex ^a   Merriam, Philip A ^b   Leung, Kathy ^b   Manheim, Larry ^a   Kibbe, Melina R ^a,c   Olendzki, Barbara ^b   Pearce, William H ^a,c   Ockene, Ira S ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Intermittent claudication; Peripheral arterial disease; Secondary prevention

Indexed keywords

HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT COUNSELING; PATIENT EDUCATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL, LDL; COUNSELING; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; TELEPHONE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79957526670     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2010.11.032     Document Type: Article

References (33)

1. C.L. Heald, F.G. Fowkes, G.D. Murray, and J.F. Price Ankle brachial index collaboration Atherosclerosis 189 2006 61 69
2. Ankle Brachial Index Collaboration Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis Jama 300 2008 197 208
3. Heart Protection Study Collaborative group MRC/BHF Heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial Lancet 360 2002 7 22
4. D.D. Waters, C. Brotons, and C.W. Chiang Lipid Treatment Assessment Project 2: a multinational survey to evaluate the proportion of patients achieving low density lipoprotein cholesterol goals Circulation 120 2009 28 34
5. M.M. McDermott, S. Mehta, H. Ahn, and P. Greenland Atherosclerotic risk factors are less intensively modified in peripheral arterial disease than in coronary artery disease J Gen Intern Med 12 1997 209 215 (Pubitemid 27175894)
6. A.T. Hirsch, M.H. Criqui, and D. Treat-Jacobson Peripheral arterial disease detection, awareness, and treatment in primary care Jama 286 2001 1317 1324 (Pubitemid 33015522)
7. E. Selvin, and A.T. Hirsch Contemporary risk factor control and walking dysfunction in individuals with peripheral arterial disease: NHANES 1999-2004 Atherosclerosis 201 2008 425 433
8. R.L. Kravitz, R.A. Bell, and R. Azari Direct observation of requests for clinical services in office practice Arch Intern Med 163 2003 1673 1681
9. O.J. Austin, S. Valente, L.A. Hasse, and J.R. Kues Determinants of prostate-specific antigen test use in prostate cancer screening by primary care physicians Arch Fam Med 5 1997 453 458 (Pubitemid 127440390)
10. M.F. Hollon Direct-to-consumer marketing of prescription drugs Creating consumer demand Jama 281 1999 382 384 (Pubitemid 29061047)
11. M.M. McDermott, K.M. Mazor, and G. Reed Attitudes and behavior of peripheral arterial disease patients toward influencing their physician's prescription of cholesterol-lowering medication Vasc Med 15 2 2009 83 90
12. S.M. Grundy, J.I. Cleeman, and C.N. Merz Coordinating Committee of the National Cholesterol Education Program Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines J Am Coll Cardiol 44 2004 720 723
13. M.M. McDermott, P. Ades, and J.M. Guralnik Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled clinical trial Jama 301 2009 165 174
14. Ryan P. Random allocation of treatment blocks 1998; Stata Technical Bulletin STB-41, 43-36. Reprinted in Stata Tech Bull Reprints. 1998;7:297-300.
15. P. Ryan Update to random allocation of treatment to blocks Stata Tech Bull 9 50 1999 37
16. R.C. Maly, J.C. Frank, and G.N. Marshall Perceived efficacy in patient-physician interactions (PEPPI): validation of an instrument in older persons J Am Geriatr Soc 46 1998 889 894 (Pubitemid 28328506)
17. J.H. Hibbard, J. Stackard, E.R. Mahoney, and M. Tusler Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers Health Serv Res 39 2004 1005 1025
18. B.L. Svarstad, B.A. Chewning, B.L. Sleath, and C. Claesson The brief medication questionnaire: a tool for screening patient adherence and barriers to adherence Patient Educ Couns 37 1999 113 124 (Pubitemid 29276860)
19. P. Jones, S. Kafonek, I. Laurora, and D. Hunninghake Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study) Am J Cardiol 81 1998 582 587 (Pubitemid 28182422)
20. J.R. Crouse 3rd, J. Frohlich, and L. Ose Effects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I Am J Cardiol 83 1999 1476 1477 (Pubitemid 29228345)
21. P.H. Jones, M.H. Davidson, and E.A. Stein Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial) Am J Cardiol 92 2003 152 160 (Pubitemid 36835963)
22. G. Beaton, J. Milner, and P. Corey Sources of variance in 24-hour dietary recall data: implications for nutrition study design and interpretation Am J Clin Nutr 32 1979 2546 2559 (Pubitemid 10177104)
23. M.J. Vale, M.V. Jelinek, J.D. Best, and J.D. Santamaria Coaching patients with coronary heart disease to achieve the target cholesterol: a method to bridge the gap between evidence-based medicine and the 'real world': randomized controlled trial J Clin Epidemiol 55 2002 245 252 (Pubitemid 34195520)
24. Hintz J. Power Analysis and Sample Size (PASS) 2003. Kasyville, UT: NCSS LLC. Available at: www.ncss.com.
25. P. Royston Multiple imputation of missing values Stata J 4 2004 227 241
26. P. Royston Multiple imputation of missing values: update of ice Stata J 5 4 2005 527 536 (Pubitemid 43708457)
27. P. Royston, J.B. Carlin, and I.R. White Multiple imputation of missing values: new features for mim Stata J 9 2 2009 252 264
28. M.M. McDermott, E.A. Hahn, and P. Greenland Atherosclerotic risk factor reduction in peripheral arterial disease: results of a national physician survey J Gen Intern Med 17 2002 895 904 (Pubitemid 35471987)
29. M.M. McDermott, A.L. Mandapat, and A. Moates Knowledge and attitudes regarding cardiovascular disease risk and prevention in patients with coronary or peripheral arterial disease Arch Intern Med 163 2003 2157 2162 (Pubitemid 37248780)
30. A. Zeller, E. Ramseier, A. Teagtmeyer, and E. Battegay Patients' self-reported adherence to cardiovascular medication using electronic monitors as comparators Hypertens Res 31 2008 2037 2043
31. M.C. Garber, D.P. Nau, and S.R. Erickson The concordance of self-report with other measures of medication adherence: a summary of the literature Med Care 42 2004 649 652
32. K. Tu, and D. Davis Can we alter physician behavior by educational methods? Lessons learned from studies of the management and follow-up of hypertension J Contin Educ Health Prof 22 2002 11 22
33. M.D. Murray, L.E. Harris, and J.M. Overhage Failure of computerized treatment suggestions to improve health outcomes in outpatients with uncomplicated hypertension: results of a randomized controlled trial Pharmacotherapy 24 2004 324 337 (Pubitemid 38298757)